Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Prot
This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min).
| Condition(s) | Diabetes Type 2, Kidney Disease |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min). |
| Who can participate | Inclusion Criteria: * Type 2 diabetes (ICD-10 DE11.x) * Age 18-74 years * BMI \< 35 kg/m² * eGFR 30-59 ml/min and UACR \> 30 mg/g * Stable medication for ≥3 months * Ability to read and understand Danish Exclusion Criteria: * Type 1 diabetes or other diabetes types * Current vegan diet * Active cancer * Short bowel syndrome or celiac disease * Use of sodium chloride tablets * No access to digital platform (intervention group only) |
| Ages | 18 Years to 74 Years |
| Sex | All |
| Lead sponsor | Steno Diabetes Center Copenhagen |
| Locations | Herlev, Captial Region of Denmark, Denmark; Hillerød, Captial Region of Denmark, Denmark |
| Start date | 2026-03-20 |
| NCT ID | NCT07485075 |
| Official listing | https://clinicaltrials.gov/study/NCT07485075 |